002793.SZ
罗欣药业
SZSE · Healthcare · C 制造业 · CN
CNY 4.66
−6.80%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−59.5x
Market Cap
CNY 5.07B
MomentumView details →
1D Return
−6.80%
YTD Return
−0.63%
RSI (14)
45.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−59.5x
Market Cap
CNY 5.07B
RSI (14)
45.0
MomentumView details →
1D Return
−6.80%
YTD Return
−0.63%
Similar companies
Latest newsMore news →
Luoxin Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders of 49.9341 million yuan, up 182.19% year-on-year.16d agoLuoxin Pharmaceutical announced that shares held by shareholders Deyi Chengdu, Deyi Health, and Desheng Health, who collectively hold more than 5% of the company, were judicially frozen, totaling 9,241,258 shares, representing 15.74% of their holdings and 0.85% of the company's total share capital, with the freeze starting on August 5 and expiring on June 15, 2029.29d ago